Document is current

Article History

Received: 17 April 2025

Accepted: 26 June 2025

First Online: 5 August 2025

Declarations

:

: Rocco Liguori has received consulting fees, honoraria for lectures or presentation from Maya Idee Sud srl, ISS, Qb Group Srl, Symposium Srl, Accademia Nazionale di Medicina, AIM Italy srl, Aristea Srl and participation to advisory board fees from Argenx; Francesco Habetswallner has received honoraria for lectures or presentation, support for attending meetings or participation to data safety monitoring board/advisory board fees from Alexion, Argenx, UCB,Roche, Merck, Janssen, Lusofarmaco, Angelini, Abbvie, IPSEN, Alfa Sigma, CLS Boering, Takeda; Michelangelo Maestri has received honoraria for lectures or presentation, support for attending meetings or participation to data safety monitoring board/advisory board fees from Alexion, Argenx, UCB, Idorsia, Bruno farmaceutica, Italfarmaco; Matteo Gastaldi has received honoraria for lectures or presentation, participation to data safety monitoring board/advisory board fees UCB, Roche, Alexion, Johnson and Johnson, Argenx; Elena Pegoraro has received consulting fees, honoraria for lectures or presentation from Alexion, UCB, Biogen, Roche, Santhera, Sanofi; Barbara Polistena has received honoraria for lectures or presentation Amgen, Amicus, UCB; Carmelo Rodolico has received support for attending meetings or participation to data safety monitoring board/advisory board fees from Alexion, Argenx, Johnson & Johnson, UCB Pharma; Giovanni Antonini has received honoraria for lectures or presentation, support for attending meetings or participation to data safety monitoring board/advisory board fees from Kedrion, Takeda, Alexion, UCB, Alnylam, Argenx. Renato Mantegazza has received support for attending meetings or participation to data safety monitoring board/advisory board fees from Alexion, Argenx, Johnson & Johnson, UCB Pharma.

: This consensus statement does not involve human participants, patient data, or interventional research requiring formal ethical approval. The recommendations presented are based on expert opinion and a review of the existing literature.